Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Merson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Sports Sciences|April 22, 2005
Fluid and electrolyte balance in elite male football (soccer) players training in a cool environmentR J Maughan, S M Shirreffs, S J Merson, et al.
International Journal of Sport Nutrition and Exercise Metabolism|July 17, 2004
Fluid and electrolyte intake and loss in elite soccer players during trainingRonald J Maughan, Stuart J Merson, Nick P Broad, et al.
The British Journal of Nutrition|June 9, 2004
The effects of fluid restriction on hydration status and subjective feelings in manSusan M Shirreffs, Stuart J Merson, Susan M Fraser, et al.
The Journal of General Virology|March 26, 1999
Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 proteinA D Wardell, W Errington, G Ciaramella, et al.
Journal of Virology|February 1, 1994
Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phaseK Nagy, M Young, C Baboonian, et al.
Biochemical and Biophysical Research Communications|August 30, 1991
HIV-1 proteinase is required for synthesis of pro-viral DNAC Baboonian, A Dalgleish, L Bountiff, et al.
Human Gene Therapy|September 19, 1998
Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapyQ Yang, M Mamounas, G Yu, et al.
Virology|October 21, 2000
Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5Y Feng, M Leavitt, R Tritz, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071W Li, P A Escarpe, E J Eisenberg, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infectionD B Mendel, C Y Tai, P A Escarpe, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Sports Sciences|April 22, 2005
Fluid and electrolyte balance in elite male football (soccer) players training in a cool environmentR J Maughan, S M Shirreffs, S J Merson, et al.
International Journal of Sport Nutrition and Exercise Metabolism|July 17, 2004
Fluid and electrolyte intake and loss in elite soccer players during trainingRonald J Maughan, Stuart J Merson, Nick P Broad, et al.
The British Journal of Nutrition|June 9, 2004
The effects of fluid restriction on hydration status and subjective feelings in manSusan M Shirreffs, Stuart J Merson, Susan M Fraser, et al.
The Journal of General Virology|March 26, 1999
Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 proteinA D Wardell, W Errington, G Ciaramella, et al.
Journal of Virology|February 1, 1994
Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phaseK Nagy, M Young, C Baboonian, et al.
Biochemical and Biophysical Research Communications|August 30, 1991
HIV-1 proteinase is required for synthesis of pro-viral DNAC Baboonian, A Dalgleish, L Bountiff, et al.
Human Gene Therapy|September 19, 1998
Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapyQ Yang, M Mamounas, G Yu, et al.
Virology|October 21, 2000
Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5Y Feng, M Leavitt, R Tritz, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071W Li, P A Escarpe, E J Eisenberg, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infectionD B Mendel, C Y Tai, P A Escarpe, et al.
Pageof 2